Provention Bio
is a New Jersey-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of autoimmune diseases... Read moreProvention Bio
is a New Jersey-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of autoimmune diseases... Read more
News
Apr 27, 2023
MarketScreener
Provention Bio: Provention Bio : Termination of Material Agreement - Form 8-K
Apr 27, 2023
FinanzNachrichten
Provention Bio: Sanofi - Aventis Groupe: Press Release: Sanofi completes acquisition of Provention Bio, Inc.
Apr 10, 2023
BioSpace
Provention Bio: Press Release: Sanofi announces withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer to acquire Provention Bio, Inc.
Mar 29, 2023
GlobalNewswire
Press Release: Provention Bio : SHAREHOLDER ALERT: Morris Kandinov Investigating PRVB, MAXR, DNA, and FOX; Shareholders are Encouraged to Contact the Firm
Mar 29, 2023
MarketScreener
Provention Bio: PROVENTION BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Provention Bio, Inc. - PRVB
Mar 26, 2023
Healthcare Weekly
Provention Bio: Sanofi Acquires Diabetes Drug Via Provention Buyout
Mar 21, 2023
GlobalNewswire
Press Release: Provention Bio : Moore Kuehn Encourages RADI, PRVB, CVT, and UNVR Investors to Contact Law Firm
Mar 15, 2023
Markets Insider
Provention Bio: Provention Bio Q4 2022 Earnings Preview (NASDAQ:PRVB)
Mar 15, 2023
Global Legal Chronicle
Provention Bio: Sanofi's $2.9 Billion Acquisition of Provention Bio
Mar 15, 2023
Americanbankingnews
Provention Bio: Provention Bio (PRVB) to Release Quarterly Earnings on Thursday
Provention Bio Competitors
1
2
3
4
5
6
7
8
9
10